CYIOS CORP
LAUNCHES HELIO CRYPTO EXCHANGE
Cryptocurrency Trading
Platform is Now Live for Non-US Residents
Boca Raton, FL -- March
1, 2022 -- InvestorsHub NewsWire -- CYIOS Corp: (OTC
PINK: CYIO), a publicly traded holding company with subsidiary
business focused on crypto-lending, crypto-trading and NFT's today
announced the live launch of its Helio Crypto Exchange for non-US
residents, with availability for US residents in certain states
anticipated for March.
Mr. John O'Shea,
Chairman of Cyios Corp commented, "The Company is well along the
way in its development plans of building a community around a one
stop shop for crypto biz. We are excited to have launched the
Helio Crypto Exchange which is now live. Sign up can be found
here, along with an online demo of the exchange: https://www.helioexchange.io/ The
Exchange will initially be available for non-US residents, followed
by certain US States expected to come online in March. US residents
can sign up for notifications here https://www.helioexchange.io/register-for-updates.
The platform offers 55+ cryptocurrencies and more than 19 Fiat
Currencies GLOBALLY. Simple and effective user experience with
multi language support. The Exchange offers trades a wide variety
of cryptocurrencies including BTC, ETH, LTC, LINK, DOT, UNI, XRP
and more, as well as offer stablecoin and fiat pairs for compliant,
safe, and truly borderless trading across AUD, USD, EUR, JPY, BTC,
ETH, USDT, BRZ, TRYB, and more. The Company's intermediate term plans
are to launch a token offering whereby users of the company's
various platforms, including Helio Lending, Helio Exchange and
Randombly (the Company's soon to launch NFT Marketplace) can
benefit from being part of the community."
CONTACT
INFORMATION
Public and Investor
Relations: admin@cyioscorporation.com
Investors are encouraged
to follow CYIOS using: www.twitter.com/cyioscorp
Follow Helio Lending:
https://heliolending.com/
https://twitter.com/heliolending
About CYIOS
Corporation
CYIOS Corporation is a
publicly traded holding company with numerous subsidiary businesses
including; Helio Lending, Helio Exchange, Randombly, and Choice
Wellness Inc. Through these operations, the Company is focused on
building a one stop shop crypto platform encompassing
crypto-currency lending through Helio's CeFi Aggregator platform,
Crypto trading through Helio Exchange, NFT minting and trading
through Randombly NFT Marketplace and Choice Wellness which is
focused on developing and marketing specialty branded products in
the Health and Wellness markets, including the "DR's CHOICE" and
"24" brand of products. The Company looks to develop, distribute,
and license proprietary products as well as evaluate potential
acquisition opportunities. Further, the Company continues to seek
and evaluate attractive business opportunities and to leverage its
resources and expertise to build a diversified, sustainable
business model.
For more information,
please visit www.cyioscorporation.com
About Helio Lending, PTY
LTD
Founded in 2018, Helio
Lending has developed a CeFi cryptocurrency lending platform, with
headquarters in Australia. Recognized as the first to market in
Australia, Helio Lending was the first independent crypto lending
company to actively lend within Australia. Helio has since evolved
and positioned itself as the first CeFi (centralized finance)
aggregator worldwide. Helio has a large panel of partners providing
access to the best rates and offers for crypto loan providers as
well as offering a competitive yield generating platform. Helio
Lending provides holders of cryptocurrency (such as Bitcoin,
Bitcoin Cash, Ethereum, Litecoin and Ripple) with a safe and secure
way to access fiat funds at the best rates, without selling any of
their cryptocurrency.
About ChoiceWellness,
Inc.
ChoiceWellness, Inc. is
a health and wellness company that has brought to market the DR's
CHOICE line of products, as well as the "24" Brand Hand Sanitizer
products. DR's CHOICE was developed with a mission to offer Doctors
and Medical Practitioners their own Professional Grade CBD BRAND
with a suite of products they could stand behind and be confident
to offer to their patients. Our customers can be assured that DR's
CHOICE CBD products have gone through the highest scrutiny of
testing for purity, potency, and quality. DR's Choice products have
been brought to market for Doctors and Medical Professionals
seeking a better solution for patients suffering from pain,
inflammation, anxiety, or other persistent symptoms. For more
information, please visit www.choicewellnessbrands.com
or email us at info@choicewellnessbrands.com
FORWARD-LOOKING
STATEMENTS: This release contains "forward-looking statements."
Forward-looking statements also may be included in other publicly
available documents issued by the Company and in oral statements
made by our officers and representatives from time to time. These
forward-looking statements are intended to provide management's
current expectations or plans for our future operating and
financial performance, based on assumptions currently believed to
be valid. They can be identified using words such as "anticipate,"
"intend," "plan," "goal," "seek," "believe," "project," "estimate,"
"expect," "strategy," "future," "likely," "may," "should," "would,"
"could," "will" & other words of similar meaning in connection
with a discussion of future operating or financial performance.
Examples of forward-looking statements include, among others,
statements relating to future sales, earnings, cash flows, results
of operations, uses of cash and other measures of financial
performance. Because forward-looking statements relate to the
future, they are subject to inherent risks, uncertainties and other
factors that may cause the Company's actual results and financial
condition to differ materially from those expressed or implied in
the forward-looking statements. Such risks, uncertainties and other
factors include, among others such as, but not limited to economic
conditions, changes in the laws or regulations, demand for products
and services of the company, the effects of competition and other
factors that could cause actual results to differ materially from
those projected or represented in the forward-looking statements.
Any forward-looking information provided in this release should be
considered w/ these factors in mind. We assume no obligation to
update any forward-looking statements contained in this
report